DDIT3 and cancer: Glabridin upregulates endoplasmic reticulum stress markers (CHOP), inducing stress and protein aggregation that disrupts cancer cell metabolism. It also increases ROS production and lowers mitochondrial membrane potential, leading to oxidative stress, impaired mitochondrial function, and cell death.